Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Add-on selegiline therapy improves negative symptoms in schizophrenia

Feb. 10, 2005

Evidence suggests gabapentin may be effective for cancer-induced bone pain

Feb. 10, 2005

Valproate reported to reduce heavy drinking in patients with bipolar disorder

Feb. 10, 2005

MethylGene and EnVivo enter into HDAC collaboration agreement

Feb. 10, 2005

PDUFA dates set for Cesamet filing

Feb. 10, 2005

Synthesis and preclinical efficacy of a peripherally selective COMT inhibitor BIA-3-335

Feb. 10, 2005

BBB-permeable metal chelator shows promise for Alzheimer's treatment

Feb. 9, 2005

Evidence suggests that antihypertensive drugs improve severity of ischemic stroke

Feb. 9, 2005

Fujisawa inlicenses ACR-16 from Carlsson Research

Feb. 9, 2005

Neurocrine prepares resubmission of indiplon NDAs

Feb. 9, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...